FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2905933821> ?p ?o ?g. }

• W2905933821 endingPage "S437" @default.
• W2905933821 startingPage "S437" @default.
• W2905933821 abstract "Survival of patients with multiple myeloma (MM) has improved significantly with access to autologous stem cell transplant (SCT) and new treatments. This study aims to describe the real-world epidemiology, treatment patterns and outcomes of MM. A retrospective database study was conducted in Maccabi Healthcare Services (MHS), a 2-million-member nationwide health plan in Israel. MM was defined by cross-linking data on MM diagnoses, dispensed treatments, and serum free light-chain assays. Prevalence (31/12/2016) and incidence (2012-2016) rates were age-standardized (WHO). Newly diagnosed and treated patients (2009-2015) were followed through 31/12/2016 for overall survival (OS) and cumulative incidence of progression to second-line (L2), with death as a competing risk. MM prevalence and incidence rates were 2.6 per 10,000 and 4.6 per 100,000 population, respectively. In the treatment cohort (N=552), mean (SD) age was 65.6 (11.3) years (60.1% male), with a median of 6 weeks from diagnosis to treatment. Median (95% CI) OS was 5.2 (4.3-6.1) years overall and 6.5 (4.9-8.1) years for first-line (L1) bortezomib (N=421). In a multivariable analysis adjusting for L1 regimen and patients characteristics and comorbiditeis, OS was significantly higher among patients who initiated L1 in 2012-2015 vs. 2009-2011. Within a year, 38.4% underwent SCT. Cumulative incidence of L2 was 38.2% and 51.4% within 1 and 2 years, respectively, and was associated with older age (≥65y; P<0.001). The results of this real-world analysis in a large heterogeneous population demonstrate MM incidence and survival rates that are in line with the literature, together with a significant improvement in overall survival over time. Approximately half of newly treated patients progressed to L2 within two years and older patients progressed significantly faster. These results will serve as a baseline for further research to evaluate the clinical impact of new interventions." @default.
• W2905933821 created "2019-01-01" @default.
• W2905933821 creator A5004968861 @default.
• W2905933821 creator A5022330655 @default.
• W2905933821 creator A5047007170 @default.
• W2905933821 creator A5051766664 @default.
• W2905933821 creator A5054537455 @default.
• W2905933821 creator A5061426528 @default.
• W2905933821 creator A5067999852 @default.
• W2905933821 creator A5068244845 @default.
• W2905933821 date "2018-10-01" @default.
• W2905933821 modified "2023-09-27" @default.
• W2905933821 title "PSY9 - REAL-WORLD EPIDEMIOLOGY, TREATMENT PATTERNS AND SURVIVAL OF MULTIPLE MYELOMA PATIENTS IN A LARGE NATIONWIDE HEALTH PLAN" @default.
• W2905933821 doi "https://doi.org/10.1016/j.jval.2018.09.2586" @default.
• W2905933821 hasPublicationYear "2018" @default.
• W2905933821 type Work @default.
• W2905933821 sameAs 2905933821 @default.
• W2905933821 citedByCount "0" @default.
• W2905933821 crossrefType "journal-article" @default.
• W2905933821 hasAuthorship W2905933821A5004968861 @default.
• W2905933821 hasAuthorship W2905933821A5022330655 @default.
• W2905933821 hasAuthorship W2905933821A5047007170 @default.
• W2905933821 hasAuthorship W2905933821A5051766664 @default.
• W2905933821 hasAuthorship W2905933821A5054537455 @default.
• W2905933821 hasAuthorship W2905933821A5061426528 @default.
• W2905933821 hasAuthorship W2905933821A5067999852 @default.
• W2905933821 hasAuthorship W2905933821A5068244845 @default.
• W2905933821 hasBestOaLocation W29059338211 @default.
• W2905933821 hasConcept C107130276 @default.
• W2905933821 hasConcept C120665830 @default.
• W2905933821 hasConcept C121332964 @default.
• W2905933821 hasConcept C126322002 @default.
• W2905933821 hasConcept C167135981 @default.
• W2905933821 hasConcept C187212893 @default.
• W2905933821 hasConcept C2776364478 @default.
• W2905933821 hasConcept C2777478702 @default.
• W2905933821 hasConcept C2781413609 @default.
• W2905933821 hasConcept C2908647359 @default.
• W2905933821 hasConcept C61511704 @default.
• W2905933821 hasConcept C71924100 @default.
• W2905933821 hasConcept C72563966 @default.
• W2905933821 hasConcept C88879693 @default.
• W2905933821 hasConcept C99454951 @default.
• W2905933821 hasConceptScore W2905933821C107130276 @default.
• W2905933821 hasConceptScore W2905933821C120665830 @default.
• W2905933821 hasConceptScore W2905933821C121332964 @default.
• W2905933821 hasConceptScore W2905933821C126322002 @default.
• W2905933821 hasConceptScore W2905933821C167135981 @default.
• W2905933821 hasConceptScore W2905933821C187212893 @default.
• W2905933821 hasConceptScore W2905933821C2776364478 @default.
• W2905933821 hasConceptScore W2905933821C2777478702 @default.
• W2905933821 hasConceptScore W2905933821C2781413609 @default.
• W2905933821 hasConceptScore W2905933821C2908647359 @default.
• W2905933821 hasConceptScore W2905933821C61511704 @default.
• W2905933821 hasConceptScore W2905933821C71924100 @default.
• W2905933821 hasConceptScore W2905933821C72563966 @default.
• W2905933821 hasConceptScore W2905933821C88879693 @default.
• W2905933821 hasConceptScore W2905933821C99454951 @default.
• W2905933821 hasLocation W29059338211 @default.
• W2905933821 hasOpenAccess W2905933821 @default.
• W2905933821 hasPrimaryLocation W29059338211 @default.
• W2905933821 hasRelatedWork W1972519999 @default.
• W2905933821 hasRelatedWork W2022680061 @default.
• W2905933821 hasRelatedWork W2145174768 @default.
• W2905933821 hasRelatedWork W2154828058 @default.
• W2905933821 hasRelatedWork W2273587585 @default.
• W2905933821 hasRelatedWork W2605580960 @default.
• W2905933821 hasRelatedWork W2975829215 @default.
• W2905933821 hasRelatedWork W3134875278 @default.
• W2905933821 hasRelatedWork W4248694421 @default.
• W2905933821 hasRelatedWork W4313857557 @default.
• W2905933821 hasVolume "21" @default.
• W2905933821 isParatext "false" @default.
• W2905933821 isRetracted "false" @default.
• W2905933821 magId "2905933821" @default.
• W2905933821 workType "article" @default.